Oppenheimer upgraded shares of AngioDynamics (NASDAQ:ANGO – Free Report) from a market perform rating to an outperform rating in a report issued on Friday, Marketbeat Ratings reports. Oppenheimer currently has $12.00 price target on the medical instruments supplier’s stock. A number of other brokerages have also recently weighed in on ANGO. Raymond James reduced their […]